Works matching Chronic myeloid leukemia

Results: 5000
    1

    Additional cytogenetic abnormalities and variant t(9;22) at the diagnosis of childhood chronic myeloid leukemia: The experience of the International Registry for Chronic Myeloid Leukemia in Children and Adolescents.

    Published in:
    Cancer (0008543X), 2017, v. 123, n. 18, p. 3609, doi. 10.1002/cncr.30767
    By:
    • Millot, Frédéric;
    • Dupraz, Christelle;
    • Guilhot, Joelle;
    • Suttorp, Meinolf;
    • Brizard, Françoise;
    • Leblanc, Thierry;
    • Güneş, Adalet Meral;
    • Sedlacek, Petr;
    • De Bont, Evelyne;
    • Li, Chi Kong;
    • Kalwak, Krzysztof;
    • Lausen, Birgitte;
    • Culic, Srdjana;
    • Dworzak, Michael;
    • Kaiserova, Emilia;
    • De Moerloose, Barbara;
    • Roula, Farah;
    • Biondi, Andrea;
    • Baruchel, André;
    • Guilhot, François
    Publication type:
    Article
    2
    3
    4

    Discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia: Recommendations for clinical practice from the French Chronic Myeloid Leukemia Study Group.

    Published in:
    2018
    By:
    • Rea, Delphine;
    • Ame, Shanti;
    • Berger, Marc;
    • Cayuela, Jean‐Michel;
    • Charbonnier, Aude;
    • Coiteux, Valérie;
    • Cony‐Makhoul, Pascale;
    • Dubruille, Viviane;
    • Dulucq, Stéphanie;
    • Etienne, Gabriel;
    • Legros, Laurence;
    • Nicolini, Franck;
    • Roche‐Lestienne, Catherine;
    • Escoffre‐Barbe, Martine;
    • Gardembas, Martine;
    • Guerci‐Bresler, Agnès;
    • Johnson‐Ansah, Hyacinthe;
    • Rigal‐Huguet, Françoise;
    • Rousselot, Philippe;
    • Mahon, François‐Xavier
    Publication type:
    journal article
    5
    6
    7
    8
    9
    10
    11
    12

    Baseline BCR-ABL1 transcript type of e13a2 and large spleen size are predictors of poor long-term outcomes in chronic phase chronic myeloid leukemia patients who failed to achieve an early molecular response after 3 months of imatinib therapy.

    Published in:
    Leukemia & Lymphoma, 2018, v. 59, n. 1, p. 105, doi. 10.1080/10428194.2017.1320711
    By:
    • Lee, Sung-Eun;
    • Choi, Soo-Young;
    • Kim, Soo-Hyun;
    • Song, Hye-Young;
    • Yoo, Hae-Lyun;
    • Lee, Mi-Young;
    • Hwang, Hee-Jeong;
    • Kang, Ki-Hoon;
    • Kee, Kyung-Mi;
    • Jang, Eun-Jung;
    • Kim, Dong-Wook
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33

    No Benefit from Hydroxyurea Pre-Treatment in Frontline Chronic Myeloid Leukemia Therapy and Evidence of Quantitative Changes in the BCR::ABL1 Transcript Level.

    Published in:
    International Journal of Molecular Sciences, 2025, v. 26, n. 5, p. 1840, doi. 10.3390/ijms26051840
    By:
    • Stagno, Fabio;
    • Stella, Stefania;
    • Leotta, Salvatore;
    • Caserta, Santino;
    • Vitale, Silvia Rita;
    • Markovic, Uros;
    • Tomarchio, Cristina;
    • Mirabile, Giuseppe;
    • Russo, Sabina;
    • Massimino, Michele;
    • Vigneri, Paolo;
    • Manzella, Livia;
    • Di Raimondo, Francesco;
    • Allegra, Alessandro
    Publication type:
    Article
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47

    Outcomes of adolescents and young adults with chronic-phase chronic myeloid leukaemia treated with tyrosine kinase inhibitors.

    Published in:
    Annals of Medicine, 2022, v. 54, n. 1, p. 1244, doi. 10.1080/07853890.2022.2069280
    By:
    • Nishiyama-Fujita, Yuriko;
    • Nakazato, Tomonori;
    • Iriyama, Noriyoshi;
    • Tokuhira, Michihide;
    • Ishikawa, Maho;
    • Sato, Eriko;
    • Takaku, Tomoiku;
    • Sugimoto, Keiji;
    • Fujita, Hiroyuki;
    • Fujioka, Isao;
    • Tsuchiya, Shun;
    • Kimura, Yuta;
    • Iwanaga, Eisaku;
    • Komatsu, Norio;
    • Asou, Norio;
    • Kizaki, Masahiro;
    • Hatta, Yoshihiro;
    • Kawaguchi, Tatsuya
    Publication type:
    Article
    48

    Sensitive Detection of Pre-Existing BCR-ABL Kinase Domain Mutations in CD34+ Cells of Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia Patients Is Associated with Imatinib Resistance: Implications in the Post-Imatinib Era.

    Published in:
    PLoS ONE, 2013, v. 8, n. 2, p. 1, doi. 10.1371/journal.pone.0055717
    By:
    • Iqbal, Zafar;
    • Aleem, Aamer;
    • Iqbal, Mudassar;
    • Naqvi, Mubashar Iqbal;
    • Gill, Ammara;
    • Taj, Abid Sohail;
    • Qayyum, Abdul;
    • ur-Rehman, Najeeb;
    • Khalid, Ahmad Mukhtar;
    • Shah, Ijaz Hussain;
    • Khalid, Muhammad;
    • Haq, Riazul;
    • Khan, Mahwish;
    • Baig, Shahid Mahmood;
    • Jamil, Abid;
    • Abbas, Muhammad Naeem;
    • Absar, Muhammad;
    • Mahmood, Amer;
    • Rasool, Mahmood;
    • Akhtar, Tanveer
    Publication type:
    Article
    49
    50